Your browser doesn't support javascript.
loading
Safety of and antibody response to the BNT162b2 COVID-19 vaccine in adolescents and young adults with underlying disease.
Shoji, Kensuke; Funaki, Takanori; Yamada, Masaki; Mikami, Masashi; Miyake, Kozue; Ueno, Saki; Tao, Chiaki; Myojin, Shota; Aiba, Hiroyuki; Matsui, Toshihiro; Ogimi, Chikara; Kato, Hitoshi; Miyairi, Isao.
Afiliación
  • Shoji K; Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan. Electronic address: shoji-k@ncchd.go.jp.
  • Funaki T; Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan.
  • Yamada M; Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan; Department for Advanced Medicine for Viral Infections, National Center for Child Health and Development, Tokyo, Japan.
  • Mikami M; Biostatistics Unit, Clinical Research Center, National Center for Child Health and Development, Tokyo, Japan.
  • Miyake K; Department of Clinical Research Promotion, National Center for Child Health and Development, Tokyo, Japan.
  • Ueno S; Department of Clinical Research Promotion, National Center for Child Health and Development, Tokyo, Japan.
  • Tao C; Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan.
  • Myojin S; Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan.
  • Aiba H; Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan.
  • Matsui T; Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
  • Ogimi C; Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan.
  • Kato H; Former Executive Director, National Center for Child Health and Development, Tokyo, Japan.
  • Miyairi I; Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan; Pediatrics, Hamamatsu University School of Medicine, Shizuoka, Japan.
J Infect Chemother ; 29(1): 61-66, 2023 Jan.
Article en En | MEDLINE | ID: mdl-36152928
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Límite: Adolescent / Adult / Child / Humans Idioma: En Revista: J Infect Chemother Asunto de la revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Límite: Adolescent / Adult / Child / Humans Idioma: En Revista: J Infect Chemother Asunto de la revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article Pais de publicación: Países Bajos